Zai Lab LTD Form 4 insider transactions

Zai Lab Ltd. Director William Lis reported the acquisition of restricted American Depositary Shares and the sale of other shares under a Rule 10b5-1 trading plan.

Zai Lab Ltd. Director Nisa Leung reported the acquisition of 10,831 American Depositary Shares (ADS) as restricted stock units, vesting in June 2026, reinforcing her commitment to the company.

Zai Lab Ltd.'s Chief Financial Officer, Chen Yajing, disposed of 9,618 American Depositary Shares (ADS) for $30 per share, as part of a Rule 10b5-1 trading plan.

Du Ying, Chairperson and CEO of Zai Lab Ltd, exercised stock options and sold American Depositary Shares (ADS) under a pre-arranged Rule 10b5-1 trading plan.

Director Scott W. Morrison of Zai Lab Ltd. sold 23,799 American Depositary Shares (ADS) on May 9, 2025, at an average price of $30.0469.

Zai Lab's Chairperson and CEO, Du Ying, exercised stock options and sold American Depositary Shares (ADS) under a pre-arranged Rule 10b5-1 trading plan.

Joshua L. Smiley, an officer at Zai Lab Ltd, reported the acquisition and disposal of American Depositary Shares (ADS) related to the vesting of Restricted Share Units (RSUs).

Chief Legal Officer of Zai Lab Ltd, Frazor Titus Edmondson III, reports acquisition and disposal of American Depositary Shares (ADS) related to vesting of Restricted Share Units (RSUs).

Du Ying, Chairperson and CEO of Zai Lab Ltd, reports acquisition and disposal of American Depositary Shares (ADS) related to vesting of Restricted Share Units (RSUs).

Yajing Chen, CFO of Zai Lab Ltd, reports the acquisition and disposal of American Depositary Shares (ADS) related to vesting Restricted Share Units (RSUs).

Rafael Amado, a Zai Lab executive, reports the acquisition and disposal of American Depositary Shares (ADS) related to vesting Restricted Share Units (RSUs).

Frazor Titus Edmondson III, Chief Legal Officer of Zai Lab Ltd, reports acquisition and disposal of American Depositary Shares (ADS) related to vesting of Restricted Share Units (RSUs).

Du Ying, Chairperson and CEO of Zai Lab Ltd, reports acquisition and disposal of American Depositary Shares (ADS) related to vesting of Restricted Share Units (RSUs).

Chief Financial Officer of Zai Lab, Yajing Chen, reports acquisition and disposal of American Depositary Shares (ADS) and Restricted Share Units (RSUs).

Rafael Amado, a Zai Lab executive, reported the acquisition and disposal of American Depositary Shares (ADS) related to the vesting and tax obligations of Restricted Share Units (RSUs).

Joshua Smiley, President and COO of Zai Lab, reports acquisition and disposal of American Depositary Shares (ADS) related to vesting of Restricted Share Units (RSUs).

Rafael Amado, a Zai Lab executive, sold 3,000 American Depositary Shares (ADS) on March 17, 2025, at a price of $38.41 per ADS, according to a Form 4 filing.

Zai Lab's Chairperson and CEO, Du Ying, reports changes in beneficial ownership due to charitable contributions and transfers to trusts for the benefit of an adult son.

Rafael Amado, a Zai Lab executive, reports the acquisition of stock options and restricted share units in the company.

Joshua L. Smiley, President and COO of Zai Lab, received stock options and restricted share units (RSUs) on March 12, 2025, according to a Form 4 filing.

Frazor Titus Edmondson III, Chief Legal Officer of Zai Lab, reports the acquisition of stock options and restricted share units (RSUs) on March 12, 2025.

Chief Financial Officer of Zai Lab Ltd, Yajing Chen, reports the acquisition of stock options and restricted share units (RSUs) in the company.

Du Ying, Chairperson and CEO of Zai Lab Ltd, reports the acquisition of stock options and restricted share units (RSUs) in the company.

Director Richard Gaynor of Zai Lab Ltd. reports the sale of 2,500 American Depositary Shares (ADS) at $35.07 per share on March 5, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Du Ying, Chairperson and CEO of Zai Lab Ltd, executed stock option exercises and sales of American Depositary Shares (ADS) under a pre-arranged Rule 10b5-1 trading plan.

Frazor Titus Edmondson III, Chief Legal Officer of Zai Lab Ltd, reports the sale of 14,544 American Depositary Shares (ADS) at a price of $32.98 per share on February 28, 2025, according to a Form 4 filing.

William Lis, a director of Zai Lab Ltd, sold 15,000 American Depositary Shares (ADSs) at a price of $32.98 per ADS on February 28, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Du Ying, Chairperson and CEO of Zai Lab Ltd, executed sales of American Depositary Shares (ADS) through stock options under a pre-arranged 10b5-1 trading plan.

Kai-Xian Chen, a director at Zai Lab, has reported the disposal of shares to cover taxes and the forfeiture of unvested restricted shares following their resignation from the board.

Rafael Amado, a Zai Lab executive, reported the acquisition and disposal of American Depositary Shares (ADS) related to the vesting and tax obligations of Restricted Share Units (RSUs).